Brain Death and Organ Donation in Tunisian Intensive Care Units
NCT ID: NCT06948669
Last Updated: 2025-04-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
104 participants
OBSERVATIONAL
2022-11-01
2023-11-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
What medical factors (e.g., type of brain injury, ICU stay duration) increased the likelihood of progressing to brain death in these patients?
What patient characteristics (e.g., age, comorbidities) influenced the risk of brain death?
What were the reasons behind low organ donation rates in Tunisia, including family refusal and hospital-level barriers?
Participants were:
Adults with severe coma (Glasgow Coma Scale ≤ 8) requiring mechanical ventilation in Tunisian ICUs.
Data were collected as part of routine medical care, including information about medical factors, patient characteristics, and family attitudes towards organ donation, without any additional interventions beyond standard care.
The study was conducted from November 2022 to November 2023 across three ICUs: Sahloul, Farhat Hached, and Mohamed Taher Maamouri Hospitals.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
s100β, NSE n GFAP in Living Donor Hepatectomy and Delirium
NCT04422925
Evaluating the Care Burden of Caregivers of Patients With Brain Injury and Determining the Influencing Factors
NCT04936360
Evaluation of Factors That Cause Secondary Brain Damage on Mortality and Morbidity in Patients Undergoing Emergency Surgery Due to Head Trauma.
NCT04555772
Postoperative Cognitive Dysfunction in Geriatric Patients
NCT00512200
Advance Directives and End-of-life Decision Making in Intensive Care Medicine in Germany
NCT01294189
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Brain death (BD) is a legally and medically recognized condition under which organ donation may occur. However, organ donation rates in Tunisia remain low compared to international benchmarks. There is a need to better understand the factors influencing the progression to brain death in ICU patients, as well as the sociocultural and institutional barriers to organ donation in this setting.
Objectives
This study aimed to:
Identify clinical predictors of brain death among critically ill patients with severe brain injuries
Explore reasons for organ donation refusal by families
Identify hospital-level barriers in the organ donation process
Study Design and Setting
This was a prospective observational cohort study conducted between November 2022 and November 2023 in three Tunisian intensive care units:
Sahloul University Hospital (trauma center)
Farhat Hached University Hospital
Mohamed Taher Maamouri Hospital
Participants
Adult patients (≥18 years) admitted with severe coma (Glasgow Coma Scale ≤ 8) requiring mechanical ventilation were included. Patients with terminal illnesses unrelated to brain injury were excluded.
Procedures Data Collection
Data were prospectively collected using a standardized form developed and validated by experts in intensive care and the Tunisian National Centre for Organ Promotion and Transplantation (CNPTO).
The collected variables included:
Demographic information (e.g., age, sex)
Clinical characteristics (e.g., Glasgow Coma Scale on ICU admission, comorbidities, primary diagnosis)
Patient outcomes (e.g., progression to brain death, ICU discharge, or death from other causes)
Length of ICU stay
Organ donation process variables (e.g., whether families were approached, family consent or refusal, organ procurement, reasons for refusal)
Family approaches were conducted by the national transplant coordination team from the CNPTO.
No experimental interventions were applied. All procedures were part of standard ICU care.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Severe coma (Glasgow Coma Scale ≤8)
Requiring mechanical ventilation
Primary diagnosis of:
Traumatic brain injury (TBI)
Hemorrhagic stroke
Other severe neurological conditions (anoxic brain injury, etc.)
Potential organ donor status (for brain death subgroup):
Meets clinical brain death criteria (absent brainstem reflexes, apnea)
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Faculty of Medicine, Sousse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Imen Slama
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Imed Chouchene, MD Professor
Role: STUDY_DIRECTOR
Intensive Care Unit University Hospital of Farhat Hached Sousse Tunis Faculty of Medicine of Sousse
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia
Sousse, , Tunisia
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Slama I, Chouchene I, Ghammam R, Durin L, Naija W, Ziadi J, Ben Saad H. Predictors of brain death and barriers to organ donation in north African intensive care units: a multicenter prospective study on severe coma patients. Libyan J Med. 2025 Dec;20(1):2545049. doi: 10.1080/19932820.2025.2545049. Epub 2025 Aug 12.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HS13-2022
Identifier Type: OTHER
Identifier Source: secondary_id
BDOD-Tunisia-2022-2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.